CHELSEAH DARLING: Open Payments
NPI 1629353347 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 16 payments from 7 companies in 2025. Trend: 2023 $383 · 2024 $1,052 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $152 |
| Journey Medical Corporation | 1 | $116 |
| Novartis Pharmaceuticals Corporation | 1 | $67 |
| LEO Pharma Inc. | 1 | $52 |
| Lilly USA, LLC | 2 | $47 |
| Janssen Biotech, Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
Products named: DUPIXENT, Rhapsido, ANZUPGO, TALTZ, TREMFYA.
Industry payments across OR — which companies pay providers there.
